The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy-A Prospective Longitudinal Study.
Saved in:
| Title: | The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy-A Prospective Longitudinal Study. |
|---|---|
| Authors: | Copaescu A; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, VIC, Australia.; Clinical Immunology and Allergy, Department of Medicine, McGill University Health Center, Montréal, QC, Canada.; The Research Institute of the McGill University Health Centre, McGill University, Montreal, QC, Canada., James F; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, VIC, Australia., Mouhtouris E; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, VIC, Australia., Vogrin S; Department of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy, VIC, Australia., Smibert OC; Department of Medicine (Austin Health), The University of Melbourne, Heidelberg, VIC, Australia., Gordon CL; Department of Medicine (Austin Health), The University of Melbourne, Heidelberg, VIC, Australia.; Department of Microbiology and Immunology, The University of Melbourne, Parkville, VIC, Australia., Drewett G; Department of Medicine (Austin Health), The University of Melbourne, Heidelberg, VIC, Australia., Holmes NE; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, VIC, Australia.; Department of Medicine (Austin Health), The University of Melbourne, Heidelberg, VIC, Australia.; Department of Critical Care, Melbourne Medical School, The University of Melbourne, Parkville, VIC, Australia., Trubiano JA; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, VIC, Australia.; Department of Medicine (Austin Health), The University of Melbourne, Heidelberg, VIC, Australia.; Department of Oncology, Sir Peter MacCallum Cancer Centre, The University of Melbourne, Parkville, VIC, Australia.; The National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Parkville, VIC, Australia. |
| Source: | Frontiers in immunology [Front Immunol] 2021 Mar 17; Vol. 12, pp. 646095. Date of Electronic Publication: 2021 Mar 17 (Print Publication: 2021). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33815405 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy-A Prospective Longitudinal Study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Copaescu+A%22">Copaescu A</searchLink>; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, VIC, Australia.; Clinical Immunology and Allergy, Department of Medicine, McGill University Health Center, Montréal, QC, Canada.; The Research Institute of the McGill University Health Centre, McGill University, Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22James+F%22">James F</searchLink>; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Mouhtouris+E%22">Mouhtouris E</searchLink>; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Vogrin+S%22">Vogrin S</searchLink>; Department of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Smibert+OC%22">Smibert OC</searchLink>; Department of Medicine (Austin Health), The University of Melbourne, Heidelberg, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Gordon+CL%22">Gordon CL</searchLink>; Department of Medicine (Austin Health), The University of Melbourne, Heidelberg, VIC, Australia.; Department of Microbiology and Immunology, The University of Melbourne, Parkville, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Drewett+G%22">Drewett G</searchLink>; Department of Medicine (Austin Health), The University of Melbourne, Heidelberg, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Holmes+NE%22">Holmes NE</searchLink>; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, VIC, Australia.; Department of Medicine (Austin Health), The University of Melbourne, Heidelberg, VIC, Australia.; Department of Critical Care, Melbourne Medical School, The University of Melbourne, Parkville, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Trubiano+JA%22">Trubiano JA</searchLink>; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, VIC, Australia.; Department of Medicine (Austin Health), The University of Melbourne, Heidelberg, VIC, Australia.; Department of Oncology, Sir Peter MacCallum Cancer Centre, The University of Melbourne, Parkville, VIC, Australia.; The National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Parkville, VIC, Australia. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2021 Mar 17; Vol. 12, pp. 646095. <i>Date of Electronic Publication: </i>2021 Mar 17 (<i>Print Publication: </i>2021). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33815405 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2021.646095 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 646095 Titles: – TitleFull: The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy-A Prospective Longitudinal Study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Copaescu A – PersonEntity: Name: NameFull: James F – PersonEntity: Name: NameFull: Mouhtouris E – PersonEntity: Name: NameFull: Vogrin S – PersonEntity: Name: NameFull: Smibert OC – PersonEntity: Name: NameFull: Gordon CL – PersonEntity: Name: NameFull: Drewett G – PersonEntity: Name: NameFull: Holmes NE – PersonEntity: Name: NameFull: Trubiano JA IsPartOfRelationships: – BibEntity: Dates: – D: 17 M: 03 Text: 2021 Mar 17 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 12 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |
